Lauren Rusckowski Duprey, Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD (TAK), sold 34,535 shares at $18.54 ($640K) on 2026-09-14, disclosed to the SEC on 2026-09-15.
Open-market sale of $640k TAK by Chief Transformation Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.